Trials / Terminated
TerminatedNCT00637858
Effect of Different Doses of Tomato Lycopene on Blood Pressure in Pre-hypertensive Otherwise Healthy Subjects
Effect of Different Doses of Tomato Lycopene on the Blood Pressure in Prehypertensives and Grade I Never Treated Otherwise Healthy Subjects
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Soroka University Medical Center · Academic / Other
- Sex
- All
- Age
- 35 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Effect of different doses of tomato extract (contain Lyc-o-Mato 6% Oleoresin which Contain: 5, 15 mg lycopene , in addition to Beta-carotene (0.15%), phytoene, and phytofluene (1%); and vitamin E (2%), phospholipids (15%), and phytosterols (0.6%) suspended in tomato oleoresin oil) compared with synthetic lycopene on blood pressure and plasma lycopene levels in never treated pre-hypertensive otherwise healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lyc-O-Mato 5mg | Daily Lyc-O-Mato 5mg with lunch for 8 weeks (After 4 weeks of placebo run in). Lyc-O-Mato 6%, Natural tomato Complex, is packed into soft gelatin capsule |
| DIETARY_SUPPLEMENT | Lyc-O-Mato 15mg | Daily Lyc-O-Mato 15mg with lunch for 8 weeks (After 4 weeks of placebo run in). Lyc-O-Mato 6%, Natural tomato Complex, is packed into soft gelatin capsule |
| DIETARY_SUPPLEMENT | Lyc-O-Mato 30mg | Daily Lyc-O-Mato 30mg with lunch for 8 weeks (After 4 weeks of placebo run in). Lyc-O-Mato 6%, Natural tomato Complex, is packed into soft gelatin capsule |
| DIETARY_SUPPLEMENT | Lycopene capsules (non Lyc-o-mato) 15 mg | Daily Lycopene capsules (non Lyc-o-mato) 15 mg with lunch for 8 weeks (After 4 weeks of placebo run in). |
| OTHER | Placebo | Placebo capsules, identical looking to previous capsules for double-blind treatment period (8 weeks) and single blind run-in (4 weeks). |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2009-12-01
- Completion
- 2011-01-01
- First posted
- 2008-03-18
- Last updated
- 2013-01-08
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00637858. Inclusion in this directory is not an endorsement.